Generate Biomedicines, Inc. Common Stock Tangible Net Worth Ratio
Generate Biomedicines, Inc. Common Stock tangible net worth ratio. Generate Biomedicines, Inc. Common Stock (GENB) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($456.05 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Generate Biomedicines, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Generate Biomedicines, Inc. Common Stock Tangible Net Worth Ratio by Year (None–None)
Generate Biomedicines, Inc. Common Stock tangible net worth ratio by year from None to None. The table below presents the year-by-year Tangible Net Worth Ratio for Generate Biomedicines, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see GENB market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|